Diabetology & Metabolic Syndrome (Jun 2010)

Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population

  • Esteghamati Alireza,
  • Zandieh Ali,
  • Khalilzadeh Omid,
  • Meysamie Alipasha,
  • Ashraf Haleh

DOI
https://doi.org/10.1186/1758-5996-2-36
Journal volume & issue
Vol. 2, no. 1
p. 36

Abstract

Read online

Abstract Background Metabolic syndrome (MetS) encompasses a cluster of coronary heart disease and diabetes mellitus risk factors. In this study, we aimed to elucidate the factors underlying the clustering of MetS components in diabetic and non-diabetic individuals. Methods Factor analysis was performed on 2978 (1652 non-diabetic and 1326 diabetic) participants. Entering waist circumference, homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides, high-density lipoprotein-cholesterol (HDL-C) and systolic blood pressure (SBP), we performed exploratory factor analysis in diabetic and non-diabetic individuals separately. The analysis was repeated after replacing triglycerides and HDL-C with triglycerides to HDL-C ratio (triglycerides/HDL-C). MetS was defined by either adult treatment panel III (ATPIII), international diabetes federation (IDF) criteria, or by the modified form of IDF using waist circumference cut-off points for Iranian population. Results The selection of triglycerides and HDL-C as two distinct variables led to identifying two factors explaining 61.3% and 55.4% of the total variance in non-diabetic and diabetic participants, respectively. In both diabetic and non-diabetic subjects, waist circumference, HOMA-IR and SBP loaded on factor 1. Factor 2 was mainly determined by triglycerides and HDL-C. Factor 1 and 2 were directly and inversely associated with MetS, respectively. When triglycerides and HDL-C were replaced by triglycerides/HDL-C, one factor was extracted, which explained 47.6% and 38.8% of the total variance in non-diabetic and diabetic participants, respectively. Conclusion This study confirms that in both diabetic and non-diabetic participants the concept of a single underlying factor representing MetS is plausible.